Reduced platelet thromboxane formation after long - term administration of a dihydropyridine calcium channel blocker : a prospective , double - blind , placebo - controlled study with nitrendipine in <font color="red">borderline_1</font> <font color="red">hypertensive_1</font> <font color="red">patients_1</font> <font color="red">with_1</font> <font color="red">IDDM_1</font> <font color="red">-_1</font> <font color="red">type_1</font> <font color="red">diabetes_1</font> <font color="red">mellitus_1</font> <font color="red">._1</font> <font color="red">
<br>
<br>_1</font> Twenty - nine IDDM patients with <font color="red">borderline_1</font> <font color="red">hypertension_1</font> were randomly allocated to placebo or nitrendipine treatment . Nitrendipine was given orally at a dosage of 20 mg once daily over 4 weeks . <font color="red">Stimulated_1</font> <font color="red">platelet_1</font> <font color="red">thromboxane_1</font> <font color="red">formation_1</font> <font color="red">at_1</font> <font color="red">rest_1</font> <font color="red">and_1</font> <font color="red">after_1</font> <font color="red">standardized_1</font> <font color="red">,_1</font> <font color="red">non_1</font> <font color="red">exhausting_1</font> <font color="red">exercise_1</font> <font color="red">was_1</font> <font color="red">measured_1</font> <font color="red">by_1</font> <font color="red">standard_1</font> <font color="red">methods_1</font> <font color="red">._1</font> <font color="red">In_1</font> <font color="red">addition_1</font> <font color="red">,_1</font> <font color="red">plasma_1</font> <font color="red">levels_1</font> <font color="red">of_1</font> <font color="red">platelet_1</font> <font color="red">factor_1</font> <font color="red">4_1</font> <font color="red">and_1</font> <font color="red">aggregation_1</font> <font color="red">responses_1</font> <font color="red">to_1</font> <font color="red">collagen_1</font> <font color="red">and_1</font> <font color="red">ADP_1</font> <font color="red">were_1</font> <font color="red">determined_1</font> <font color="red">._1</font> In the treatment group thromboxane formation after stimulation with collagen ( 0.3 and 1.0 micrograms / ml ) and 1 mM <font color="red">arachidonic_1</font> <font color="red">acid_1</font> <font color="red">(_1</font> <font color="red">AA_1</font> <font color="red">)_1</font> was reduced in the resting state . <font color="red">Exercise_3</font> <font color="red">induced_3</font> <font color="red">change_3</font> <font color="red">of_3</font> <font color="red">thromboxane_4</font> <font color="red">synthesis_4</font> <font color="red">in_1</font> <font color="red">response_1</font> <font color="red">to_1</font> <font color="red">1.0_1</font> <font color="red">micrograms_1</font> <font color="red">/_1</font> <font color="red">ml_1</font> <font color="red">collagen_1</font> was significantly lower as compared to placebo ( p < 0.05 ) . In parallel , <font color="red">PF4_3</font> <font color="red">plasma_3</font> <font color="red">levels_3</font> were significantly lowered ( p < 0.05 ) . <font color="red">Whole_4</font> <font color="red">blood_4</font> <font color="red">aggregation_4</font> <font color="red">after_2</font> <font color="red">collagen_2</font> <font color="red">stimulation_2</font> ( 1.0 micrograms / ml ) was reduced after 4 weeks of nitrendipine treatment , but <font color="red">ADP_2</font> <font color="red">(_2</font> <font color="red">5_2</font> <font color="red">microM_2</font> <font color="red">)_2</font> <font color="red">induced_2</font> <font color="red">aggregation_2</font> was not . These <font color="red">effects_1</font> of nitrendipine were not seen in platelet rich plasma . In conclusion long - term nitrendipine treatment may inhibit <font color="red">collagen_2</font> <font color="red">dependent_2</font> <font color="red">platelet_2</font> <font color="red">activation_2</font> in the blood of diabetic patients with borderline hypertension .